We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.63%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.45B
AUM Growth
+$192M
(+4.5%)
Cap. Flow
+$96.4M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
37.03%
Holding
3,677
New
275
Increased
1,530
Reduced
993
Closed
158
Avg Time Held Equity + Options
4.4
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
3.6
years
Avg Time Held Equity only
4.4
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
3.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$18.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$15.5M |
| 3 |
PIMCO Ultra Short Government Active ETF
BILZ
|
+$6.8M |
| 4 |
JPMorgan Active Bond ETF
JBND
|
+$5.14M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$5.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
+$8.95M |
| 2 |
Palantir
PLTR
|
+$7.81M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$5.25M |
| 4 |
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
+$3.68M |
| 5 |
UnitedHealth
UNH
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 16.97% |
| 3 | Healthcare | 8.95% |
| 4 | Financials | 7.08% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
Tejon Ranch
TRC
$447M
| $1.06K | ﹤0.01% |
67
+6
| +10% | +$97 |
2024 Q1
3 quarters
|
|
3077
Rhythm Pharmaceuticals
RYTM
$6.06B
| $1.06K | ﹤0.01% |
19
| – | – |
2023 Q4
4 quarters
|
|
3078
Cannae Holdings
CNNE
$704M
| $1.05K | ﹤0.01% |
53
-42
| -44% | -$841 |
2023 Q4
4 quarters
|
|
3079
Central Garden & Pet Co
CENT
$2.63B
| $1.05K | ﹤0.01% |
27
| – | – |
2020 Q1
19 quarters
|
|
3080
Protagonist Therapeutics
PTGX
$8.84B
| $1.04K | ﹤0.01% |
27
-16
| -37% | -$698 |
2024 Q2
2 quarters
|
|
3081
AFC Gamma
AFCG
$69.7M
| $1.03K | ﹤0.01% |
124
| – | – |
2022 Q3
9 quarters
|
|
3082
LiveRamp
RAMP
$2.28B
| $1.03K | ﹤0.01% |
34
| – | – |
2024 Q3
1 quarter
|
|
3083
Bandwidth Inc
BAND
$1.6B
| $1.02K | ﹤0.01% |
60
+21
| +54% | +$394 |
2020 Q2
18 quarters
|
|
3084
Axsome Therapeutics
AXSM
$8.47B
| $1.01K | ﹤0.01% |
12
| – | – |
2024 Q2
2 quarters
|
|
3085
DELISTED
Couchbase
BASE
| $1.01K | ﹤0.01% |
65
-149
| -70% | -$2.54K |
2022 Q4
8 quarters
|
|
3086
Willamette Valley Vineyards
WVVI
$10.5M
| $1K | ﹤0.01% |
300
| – | – |
2016 Q4
32 quarters
|
|
3087
Shoals Technologies Group
SHLS
$1.31B
| $1K | ﹤0.01% |
181
-1,019
| -85% | -$5.17K |
2024 Q2
2 quarters
|
|
3088
Safehold
SAFE
$818M
| $998 | ﹤0.01% |
54
| – | – |
2016 Q4
32 quarters
|
|
3089
Immunome
IMNM
$2.05B
| $988 | ﹤0.01% |
93
+65
| +232% | +$785 |
2024 Q2
2 quarters
|
|
3090
Morgan Stanley Pathway Small-Mid Cap Equity ETF
MSSM
$686M
| $984 | ﹤0.01% |
+21
| New | +$1.01K |
2024 Q4
0 quarters
|
|
3091
Burford Capital
BUR
$722M
| $982 | ﹤0.01% |
77
-4
| -5% | -$54 |
2024 Q3
1 quarter
|
|
3092
Prothena Corp
PRTA
$436M
| $970 | ﹤0.01% |
+70
| New | +$1.1K |
2024 Q4
0 quarters
|
|
3093
Q/C Technologies Inc
QCLS
$4.57M
| $964 | ﹤0.01% |
8
| – | – |
2023 Q1
7 quarters
|
|
3094
Codexis
CDXS
$141M
| $954 | ﹤0.01% |
200
| – | – |
2024 Q1
3 quarters
|
|
3095
Bitwise Bitcoin Strategy Optimum Roll ETF
BITC
$14.1M
| $947 | ﹤0.01% |
+20
| New | +$1.19K |
2024 Q4
0 quarters
|
|
3096
DELISTED
Anywhere Real Estate
HOUS
| $944 | ﹤0.01% |
286
+6
| +2% | +$26 |
2024 Q3
1 quarter
|
|
3097
Immunovant
IMVT
$5.68B
| $941 | ﹤0.01% |
+38
| New | +$1.08K |
2024 Q4
0 quarters
|
|
3098
Leonardo DRS
DRS
$9.47B
| $937 | ﹤0.01% |
29
| – | – |
2024 Q2
2 quarters
|
|
3099
Silvercorp Metals
SVM
$2.16B
| $936 | ﹤0.01% |
312
+148
| +90% | +$584 |
2024 Q3
1 quarter
|
|
3100
DELISTED
Allakos
ALLK
| $932 | ﹤0.01% |
770
| – | – |
2020 Q1
19 quarters
|
|
Similar funds
Parallel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Parallel Advisors held 3,677 positions worth $4.45B, up 4.5% from $4.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q4 2024 filing shows 275 new, 1,530 increased, 993 reduced and 158 closed positions. Its largest new stake was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M. The largest sale was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, an estimated $8.95M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q4 2024 buy was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M.
- Parallel Advisors added most to Crown Castle in Q4 2024, an estimated $18.7M increase.
- Parallel Advisors's biggest Q4 2024 reduction was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, cutting an estimated $8.95M.
- Parallel Advisors fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $3.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.45B portfolio in Q4 2024.
- Parallel Advisors opened 275 new positions and closed 158 in Q4 2024.
- Parallel Advisors's portfolio value rose 4.5% quarter-over-quarter to $4.45B.
Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.